about
The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant RecipientsABO-compatible liver allograft antibody-mediated rejection: an update.The HLA class II Allele DRB1*1501 is over-represented in patients with idiopathic pulmonary fibrosis.Genetic polymorphisms influence mycophenolate mofetil-related adverse events in pediatric heart transplant patients.Upper-extremity transplantation using a cell-based protocol to minimize immunosuppressionAlemtuzumab preconditioning with tacrolimus monotherapy-the impact of serial monitoring for donor-specific antibody.Inosine 5'-monophosphate dehydrogenase 1 haplotypes and association with mycophenolate mofetil gastrointestinal intolerance in pediatric heart transplant patients.Four-color flow cytometric analysis of peripheral blood donor cell chimerismKidney transplantation under minimal immunosuppression after pretransplant lymphoid depletion with Thymoglobulin or Campath.Use of alemtuzumab and tacrolimus monotherapy for cadaveric liver transplantation: with particular reference to hepatitis C virus.ALLOREACTIVE T LYMPHOCYTES CULTURED FROM LIVER TRANSPLANT BIOPSIES: ASSOCIATIONS OF HLA SPECIFICITY WITH CLINICOPATHOLOGICAL FINDINGSFunctional characteristics of lymphocytes propagated from a human multivisceral allograft.The kSORT assay to detect renal transplant patients at high risk for acute rejection: results of the multicenter AART study.A novel variant L263F in human inosine 5'-monophosphate dehydrogenase 2 is associated with diminished enzyme activity.Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.Antithymocyte globulin facilitates alloreactive T-cell apoptosis by means of caspase-3: potential implications for monitoring rejection-free outcomes.HLA-A01-, -A03-, and -A024-binding nanomeric epitopes in polyomavirus BK large T antigen.Tolerance to incompatible ABO blood group antigens is not observed following homograft implantation.Anti-HLA antibody analysis and crossmatching in heart and lung transplantation.Long-term effects of alemtuzumab on regulatory and memory T-cell subsets in kidney transplantationRevision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection.Acute antibody-mediated rejection of cardiac transplants.IgG Donor-Specific Anti-Human HLA Antibody Subclasses and Kidney Allograft Antibody-Mediated Injury.Anti-HLA alloantibodies in pediatric solid organ transplantation.Utility of C4d immunostaining in the first year after pediatric and young adult heart transplantation.Heart and lung transplantation in children.HLA antibody analysis: sensitivity, specificity, and clinical significance in solid organ transplantation.Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipientsEffect of cytokine and pharmacogenomic genetic polymorphisms in transplantationRetransplant candidates have donor-specific antibodies that react with structurally defined HLA-DR,DQ,DP epitopes.Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance.Report from a consensus conference on antibody-mediated rejection in heart transplantationElevated myeloid: plasmacytoid dendritic cell ratio associates with late, but not early, liver rejection in children induced with rabbit anti-human thymocyte globulin.Clinical impact of cytokine and growth factor genetic polymorphisms in thoracic organ transplantation.Delayed onset CMV disease in solid organ transplant recipients.Report from a consensus conference on the sensitized patient awaiting heart transplantationThe impact of EBV load on T-cell immunity in pediatric thoracic transplant recipients.Significance of Anti-HLA Antibodies on Adult and Pediatric Heart Allograft Outcomes.Plasma inflammatory mediators associated with bone metabolism in COPDMulti-institutional Study of Outcomes After Pediatric Heart Transplantation: Candidate Gene Polymorphism Analysis of ABCC2.
P50
Q26774993-6021144F-1F00-49B6-AEFF-77B9CA4202A2Q33422561-A750D4D5-7301-4FE2-ADF6-73706A114CC9Q33836744-798850D2-6273-4A4F-8A78-48746F2D1170Q34091823-479DE5B8-EE78-488D-9A48-515459B204FFQ34171957-162B4062-1A22-49C9-86FD-7131858DD2B1Q34187625-8B07F1EE-A756-40CF-AC28-E02C52ECFA6FQ34203809-42BB96D7-DE88-4690-B41B-9AC2ECFBCA9CQ34240854-77CF8CA6-53E0-4387-B210-C3008FB8A746Q34304820-D79F912B-2759-400C-9685-AEA0DB3879B6Q34359751-79403C47-F33E-4341-88A6-539BCA0E36A3Q34396506-93E72E2D-7819-4B57-B094-8EA3210B53E8Q34396773-730050C2-066B-4C01-9025-0BE0C556A6AEQ34489123-15027BC5-D578-432E-BF9A-79025B7BFE1DQ34627625-E510D3BE-5D6B-4CE7-8C43-68D5E70E27BAQ34728157-C9229791-7AC8-401A-A954-79553619047DQ34762189-9495F085-9C06-44BB-ABD4-F82BDA836B7CQ34909392-BBECF24B-9C66-447D-8900-C682D3BA480DQ35223723-248BE1BC-A7BE-4686-90F4-66DCAFC4E685Q35808818-BCB55774-620B-4521-9184-3654D71AF5BCQ35881889-4E834ACC-F8C1-4BC1-966C-372D4FE79065Q36317528-E8900BC6-4A61-4EA8-AFA6-F12391AD36A6Q36381735-687DE44E-FD6B-421C-9B0C-A8F606E96B1CQ36417907-FD7BB47A-4997-4302-997E-D23DD99FE3E6Q36435828-A7392819-830A-438F-84F7-33B1A7E3B9B4Q36488525-2798E86B-89E8-4C94-A11E-DF951C226DCBQ36525284-594AD59A-3C67-48C6-BFCE-6F844C4A70E9Q36751659-24E404E8-8484-449D-9C46-0FE3DB732753Q36772957-3BFABE19-536D-446A-B6DA-39099E499BDDQ37244838-130013AB-17C0-49DB-966B-B4FA10F1CAC7Q37300446-92716D0D-DABF-4C14-AA57-8502F2936F00Q37309444-C5D84586-2250-4F8F-B826-2AE3BEAA57E3Q37313051-D8DCDC1C-CAB2-4B0F-9CFD-F1425A23668DQ37317873-F866305F-A4E7-4496-883E-D3061210B68DQ37332942-D9043B1E-5EEA-4BF8-901B-F4D2D861718FQ37375243-55EFEFF4-DD2A-45A8-94FA-4F4F2DFD3063Q37414657-3FA2ACA7-A036-4952-BC0D-E91190E817F6Q37415188-F2D6C1E1-3146-4AD2-9F40-1D09551A815BQ37609092-4FDED03A-F96F-4ABB-9655-4D624EA708B1Q37700518-8763007E-8A33-4326-833A-E8E5DFC601A7Q37721951-CDEF7744-6CAF-4FA8-B4E3-5350BB667E82
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Adriana Zeevi
@ast
Adriana Zeevi
@en
Adriana Zeevi
@es
Adriana Zeevi
@nl
type
label
Adriana Zeevi
@ast
Adriana Zeevi
@en
Adriana Zeevi
@es
Adriana Zeevi
@nl
altLabel
A Zeevi
@en
A. Zeevi
@en
Zeevi A
@en
Zeevi A.
@en
Zeevi
@en
prefLabel
Adriana Zeevi
@ast
Adriana Zeevi
@en
Adriana Zeevi
@es
Adriana Zeevi
@nl
P106
P21
P31
P496
0000-0002-7540-5016